EP Plenary session - Joint debate on Patents

Patenty i prawo do ochrony odmian roślin (debata)

Patents and plant breeders rights (debate)

Utworzenie jednolitego systemu ochrony patentowej - Jednolity system ochrony patentowej - Sądowniczy system rozstrzygania sporów patentowych (debata)

Creation of unitary patent protection - Unitary patent protection - Jurisdictional system for patent disputes (debate)

Opatentowanie podstawowych procesów biologicznych (debata)

Patenting of essential biological processes (debate)

Workshop - Policy Departements and Administration : Stem cell Research and patenting

ENVI

Wzmocniona współpraca w dziedzinie tworzenia jednolitego systemu ochrony patentowej (debata)

Enhanced cooperation in the area of the creation of unitary patent protection (debate)

JURI committee meeting. Exchange of views with Romanian Presidency. Presentation of study on Essential Patents and Internet of Things, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of JURI committee

Public Hearing - The Unitary patent : state of play in the context of Brexit

PAPADIMOULIS, Dimitrios (GUE/NGL, GR) - EP Vice-President

Plenary session week 51 2015 in Strasbourg - Patents and plant breeders rights - Oral question

Green meeting about patenting food and GMOs

JURI committee Hearing on Patent

Andreas MAVROYIANNIS, Raffaele BALDASSARRE, Martin SCHULZ - EP President

Lex Signing: European Unitary Patent Package

Plenary session week 50 -2012  in Strasbourg - European Patent

Press conference on the campaign against the patenting of biotechnical discoveries - No Patents on Life - with Nobel Prize for Literature winner Dario FO.

Martin SCHULZ - EP President, Evelyne GEBHARDT

Evelyne GEBHARDT and  M. THEN from No patents on Seeds Hand over a letter to Martin SCHULZ EP-President

Carl SCHLYTER, Raul ROMEVA I RUEDA, Elisabeth SCHROEDTER, Isabelle DURANT, Jose BOVE, Franziska BRANTNER, Martin HAUSLING, Jean-Paul BESSET, Nikos CHRYSOGELOS, Ulrike LUNACEK, Franziska KELLER

Greens / EFA group members stage a protest against patents in the agriculture sector

JURI Committee Meeting - Enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements

Illustration on the EU Patent at the Belgian Intellectual Property Office.

Press Conference on Biotechnical patents by: Eva LICHTENBERGER (Greens/EFA, AT) - Vittorio PRODI (S&D, IT) - Peter LIESE (EPP, DE)  - Miroslav MIKOLJIK (EPP, SL) - Carlo CASINI (EPP, IT)

Press conference in Strasbourg  : TRIPS and access to medicines - TRIPS : The EP was due to vote on whether to grant its assent to amending the TRIPS agreement to enable developing countries to make or import generic substitutes for patented medicines

Conference in Brussels on the European Patients' Rights day

No Software Patents demonstration at the EP in Strasbourg.

No Software Patents demonstration by the GreensEFA.

Intellectual property lies at the heart of innovation and competitiveness around the world as well as in the European Union. Intellectual property rights are protected mainly through patents, trademarks and copyright. They enable individuals and companies to earn recognition and/or financial benefit from what they invent or create. By striking the right balance between innovators and public interest, intellectual property aims to foster an environment in which creativity and innovation can flourish. But despite impressive patent activity, European businesses still encounter various challenges to register or protect patents. Restrictions: ©The material may not be edited and must be shown entirely.

EPRS - Key challenges for European patents

Parlament debatował nad tym, czy należy uchylić patenty na szczepionki przeciw COVID-19 oraz przyjął bardziej integracyjny program Erasmus +. W porządku obrad znalazł się również klimat. Europosłowie zaaprobowali Fundusz Sprawiedliwej Transformacji, aby pomóc regionom w przystosowaniu się do zielonej transformacji i wezwali UE, by uczyniła więcej w zakresie ochrony działaczy na rzecz środowiska. Posłowie rozmawiali również na temat eskalacji konfliktu izraelsko-palestyńskiego.

Najważniejsze wydarzenia z sesji plenarnej: Patenty na szczepionkę na COVID-19, Erasmus + i środowisko

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate proposal to the WTO to waive intellectual property rights for COVID-19 vaccines, a move backed by the US administration. Extracts from the debate: statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs, Valdis DOMBROVSKIS, Executive Vice-President of the EC in charge of an Economy that works for People, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Dacian CIOLOŞ (Renew, RO), Tilly METZ (Greens/EFA, LU), Marc BOTENGA (The Left, BE), and Gilles LEBRETON (ID, FR).

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade and by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs and by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade.

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

Parlament ponowił swój apel o pozbawiony barier dostęp do materiału do hodowli roślin. Europosłowie chcą zagwarantować, aby rolnicy w całej UE mogli korzystać z innowacji, by znaleźć rozwiązania na kryzys klimatyczny i nowe choroby roślin. Bogate firmy nie powinny patentować życia naturalnego, co z kolei prowadzi do tworzenia monopolu i podnosi ceny żywności.

Koniec z patentami na rośliny i nasiona otrzymywane w naturalny sposób

Ostatnia prosta na drodze do unijnego patentu wymaga sporego wysiłku, ale nowy uproszczony system ma zmniejszyć koszt patentu nawet o 32 tysiące euro.

Tańsze patenty

Jednolity patent przyniesie spore korzyści europejskim firmom, uważa Raffaele Baldassare.  Sophia in 't Veld wskazuje europejskie  państwa łamiące prawa podsatwowe.

7 Dni w Europie: Bitwa o lepsze prawa i unijny patent

Po 30 latach negocjacji to może być ostatnie starcie w sprawie europejskiego patentu. Zapytaliśmy o opinie na jego temat dwóch europosłów: Bernharda Rapkay'a i Antonio Masipa Hidalgo.

Punkt widzenia: Europejski patent - ostatnia prosta?

W tym wydaniu wiadomości: prace nad europejskim patentem, kwestionowana integralność państw oraz pomoc finansowa dla Hiszpanii i żądania podniesienia cen mleka.

Europejski patent/ Loty CIA / Hiszpania / Mleko

Po burzy, jaką rozpętały zmiany wprowadzone przez Radę, PE zajmie się przyszłością patentu europejskiego.

Problematyczny patent

2.000 euro w USA i aż do 40.000 euro w Europie. Wspólny patent powinien sprawić, że procedura będzie mniej skomplikowana i tańsza, ale jej wdrożenie to już inna sprawa.

Reporter: Patent ważny na całym kontynencie

Ochrona wynalazków w całej UE być może będzie realna za niższą cenę, ale diabeł tkwi w szczegółach. Oraz pozostałe aktualności dnia.

Wiadomości: Europejski patent zgłoszony

Ochrona wynalazków w całej UE być może będzie realna za niższą cenę, ale diabeł tkwi w szczegółach.

Skuteczniejsze wykorzystanie zasobów, wspólny patent i przesłuchanie komisarza - to tylko część tego, co czeka posłów po powrocie do Brukseli.

Wyświetlanie 5 wyników dla przekazu na żywo ""